Income Statement QHSLab, Inc.

Stocks

USAQ

US90350R1077

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 10:30:41 29/05/2026 pm IST			5-day change	1st Jan Change
0.5000 ^USD	-24.24%		+56.25%	-17.48%

12/08	QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
14/05	QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

1916aecd8823c085c32.kg2o8rmZVcvgSGI4rIQd5FWWoRqZlkp9ACcrZ8wlhuw.qkb-po2pEOatfjJe7el2jDLS5k3o1CE3YhRoUZZgzd_ravqX4K0_-JUlNw

Published financial data: QHSLAB, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	14.14L	12.43L	14.09L	21.32L	26.92L
Total Revenues	14.14L	12.43L	14.09L	21.32L	26.92L
Cost of Goods Sold, Total	7L	6L	6L	8L	9L
Gross Profit	7L	6L	8L	13.58L	18.11L
Selling General & Admin Expenses, Total	10.46L	9L	7L	8L	11.23L
R&D Expenses	90.87T	2L	2L	3L	5L
Amortization of Goodwill and Intangible Assets - (IS)	36.06T	72.11T	72.11T	72.11T	72.11T
Other Operating Expenses, Total	11.73L	11.8L	10.34L	11.52L	16.8L
Operating Income	-5L	-6L	-2L	2L	1L
Interest Expense, Total	-2L	-4L	-2L	-5L	-2L
Net Interest Expenses	-2L	-4L	-2L	-5L	-2L
Other Non Operating Income (Expenses)	-	-	2.29T	78	-1L
EBT, Excl. Unusual Items	-7L	-10L	-5L	-3L	-2L
Other Unusual Items	-21.43T	-2.02T	-	-	7L
EBT, Incl. Unusual Items	-8L	-10L	-5L	-3L	5L
Earnings From Continuing Operations	-8L	-10L	-5L	-3L	5L
Net Income to Company	-8L	-10L	-5L	-3L	5L
Net Income - (IS)	-8L	-10L	-5L	-3L	5L
Net Income to Common Incl Extra Items	-8L	-10L	-5L	-3L	5L
Net Income to Common Excl. Extra Items	-8L	-10L	-5L	-3L	5L
Per Share Items
Net EPS - Basic	-0.1	-0.11	-0.05	-0.03	0.04
Basic EPS - Continuing Operations	-0.1	-0.11	-0.05	-0.03	0.04
Basic Weighted Average Shares Outstanding	78.61L	89.97L	94.17L	1.03Cr	1.13Cr
Net EPS - Diluted	-0.1	-0.11	-0.05	-0.03	0.02
Diluted EPS - Continuing Operations	-0.1	-0.11	-0.05	-0.03	0.02
Diluted Weighted Average Shares Outstanding	78.61L	89.97L	94.17L	1.03Cr	1.93Cr
Normalized Basic EPS	-0.06	-0.07	-0.03	-0.02	-0.01
Normalized Diluted EPS	-0.06	-0.07	-0.03	-0.02	-0.01
Supplemental Items
EBITDA	-5L	-5L	-2L	3L	2L
EBITA	-5L	-5L	-2L	3L	2L
EBIT	-5L	-6L	-2L	2L	1L
Normalized Net Income	-5L	-6L	-3L	-2L	-1L
Interest on Long-Term Debt	2L	4L	-	-	-
Supplemental Operating Expense Items
Marketing Expenses	5L	-	-	-	-
Selling and Marketing Expenses	6L	5L	5L	5L	7L
General and Administrative Expenses	5L	4L	3L	3L	4L
Research And Development Expense From Footnotes	90.87T	2L	3L	4L	5L
Stock-Based Comp., R&D Exp. (Total)	64.71T	30.08T	6T	1.26T	7.55T
Stock-Based Comp., S&M Exp. (Total)	98.33T	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	71.45T	6.97T	-	-	19.25T
Stock-Based Comp., Other (Total)	-	-	-	13.84T	-
Total Stock-Based Compensation	2L	37.05T	6T	15.1T	26.8T

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	3L	2L	51.58T	2L	6L
Total Cash And Short Term Investments	3L	2L	51.58T	2L	6L
Accounts Receivable, Total	70.47T	47.73T	71.38T	2L	2L
Total Receivables	70.47T	47.73T	71.38T	2L	2L
Inventory	65.74T	51.84T	25.18T	41.78T	35.79T
Prepaid Expenses	22.71T	7.31T	7.99T	25.79T	20.45T
Total Current Assets	4L	3L	2L	4L	9L
Other Intangibles, Total	17.63L	16.72L	15.25L	13.79L	12.88L
Total Assets	22.08L	19.57L	16.81L	18L	21.71L
Liabilities
Accounts Payable, Total	20.37T	85.74T	78.91T	3L	3L
Accrued Expenses, Total	-	-	26.52T	36.55T	-
Short-term Borrowings	-	4L	4L	5L	91.08T
Current Portion of Long-Term Debt	8L	10.64L	13.42L	12.6L	1L
Other Current Liabilities	58.62T	1L	2L	3L	-73.23T
Total Current Liabilities	9L	17.07L	20.57L	24.07L	4L
Long-Term Debt	5L	2L	-	-	96.22T
Other Non Current Liabilities	6.52T	-	-	-	-
Total Liabilities	13.84L	18.81L	20.57L	24.07L	5L
Preferred Stock Convertible	372	372	372	372	372
Total Preferred Equity	372	372	372	372	372
Common Stock, Total	876	932	974	1.08T	1.5T
Additional Paid In Capital	33.49L	35.9L	36.06L	37.22L	55.27L
Retained Earnings	-25.19L	-35.15L	-39.83L	-43.31L	-39.04L
Comprehensive Income and Other	-6.97T	-	-	-	-
Total Common Equity	8L	75.87T	-4L	-6L	16.25L
Total Equity	8L	76.24T	-4L	-6L	16.25L
Total Liabilities And Equity	22.08L	19.57L	16.81L	18L	21.71L
Supplemental Items
ECS Total Shares Outstanding on Filing Date	88.16L	93.16L	1.02Cr	1.13Cr	1.5Cr
ECS Total Common Shares Outstanding	87.56L	93.16L	97.36L	1.08Cr	1.5Cr
Book Value / Share	0.09	0.01	-0.04	-0.06	0.11
Tangible Book Value	-9L	-15.96L	-19.01L	-19.87L	3L
Tangible Book Value Per Share	-0.11	-0.17	-0.2	-0.18	0.02
Total Debt	12.99L	16.79L	17.82L	17.36L	3L
Net Debt	10.12L	15L	17.3L	15.79L	-3L
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Finished Goods, Total	65.74T	51.84T	25.18T	41.78T	35.79T
Full Time Employees	5	4	4	4	12
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	8.23T	18.44T	22.72T	30T

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-8L	-10L	-5L	-3L	5L
Amortization of Goodwill and Intangible Assets - (CF)	36.06T	72.11T	72.11T	72.11T	72.11T
Depreciation & Amortization, Total	36.06T	72.11T	72.11T	72.11T	72.11T
Amortization of Deferred Charges, Total - (CF)	2L	4L	2L	74.46T	18.62T
Stock-Based Compensation (CF)	2L	37.05T	6T	15.1T	21T
Provision and Write-off of Bad Debts	-	8.23T	10.22T	4.28T	7.28T
Other Operating Activities, Total	21.43T	2.02T	-	-	-6L
Change In Accounts Receivable	-9.95T	14.51T	-33.86T	-1L	-1.8T
Change In Inventories	33.96T	13.9T	26.66T	-16.6T	5.99T
Change In Accounts Payable	-1L	65.37T	-6.84T	3L	-14.53T
Change in Other Net Operating Assets	70.62T	69.97T	75.9T	1L	2L
Cash from Operations	-4L	-4L	-2L	1L	2L
Sale (Purchase) of Intangible assets	-2L	-37.12T	-	-	-
Cash from Investing	-2L	-37.12T	-	-	-
Short Term Debt Issued, Total	-	-	3.24T	10.3T	90.97T
Long-Term Debt Issued, Total	9L	6L	4L	1L	1L
Total Debt Issued	9L	6L	4L	2L	2L
Short Term Debt Repaid, Total	-	-	-	-	-14.5T
Long-Term Debt Repaid, Total	-2L	-4L	-4L	-2L	-4L
Total Debt Repaid	-2L	-4L	-4L	-2L	-4L
Issuance of Common Stock	30T	50T	-	-	5L
Other Financing Activities, Total	-85T	-30T	-	-	-
Cash from Financing	7L	3L	32.52T	-36.85T	3L
Net Change in Cash	2L	-1L	-1L	1L	5L
Supplemental Items
Cash Interest Paid	43.02T	71.78T	61.3T	2L	80.71T
Levered Free Cash Flow	-3L	-11.78T	17.81T	2L	-4L
Unlevered Free Cash Flow	-3L	-46.87T	77.79T	5L	-2L
Change In Net Working Capital	67.74T	-2L	-75.31T	-2L	4L
Net Debt Issued / Repaid	8L	3L	32.52T	-36.85T	-2L

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-25.05	-16.82	-8.25	7.39	4.13
Return on Total Capital	-29.26	-18.07	-9.5	10.14	5.39
Return On Equity %	-713.99	-221.26	312.9	52.72	89.94
Return on Common Equity	-715.58	-221.44	312.12	52.68	90
Margin Analysis
Gross Profit Margin %	47.42	49.83	56.32	63.69	67.27
SG&A Margin	73.96	73.83	53.06	36.85	41.71
EBITDA Margin %	-32.96	-39.29	-11.93	13.03	7.55
EBITA Margin %	-32.96	-39.29	-11.93	13.03	7.55
EBIT Margin %	-35.51	-45.09	-17.04	9.65	4.88
Income From Continuing Operations Margin %	-54.45	-80.12	-33.24	-12.16	16.99
Net Income Margin %	-54.45	-80.12	-33.24	-12.16	16.99
Net Avail. For Common Margin %	-54.45	-80.12	-33.24	-12.16	16.99
Normalized Net Income Margin	-33.09	-49.97	-20.78	-7.6	-4.84
Levered Free Cash Flow Margin	-18.8	-0.95	1.26	11.24	-13.01
Unlevered Free Cash Flow Margin	-18.78	-3.77	5.52	24.87	-7.5
Asset Turnover
Asset Turnover	1.13	0.6	0.77	1.22	1.36
Receivables Turnover (Average Receivables)	21.59	21.03	23.66	15.94	13.92
Inventory Turnover (Average Inventory)	8.99	10.61	15.98	23.12	22.71
Short Term Liquidity
Current Ratio	0.51	0.17	0.08	0.17	1.96
Quick Ratio	0.41	0.13	0.06	0.15	1.84
Operating Cash Flow to Current Liabilities	-0.41	-0.21	-0.08	0.06	0.4
Days Sales Outstanding (Average Receivables)	16.9	17.35	15.43	22.96	26.22
Days Outstanding Inventory (Average Inventory)	40.6	34.41	22.84	15.83	16.07
Average Days Payable Outstanding	42.63	31.76	51.04	97.18	139.21
Cash Conversion Cycle (Average Days)	14.87	20	-12.77	-58.39	-96.93
Long Term Solvency
Total Debt/Equity	157.62	2.2T	-474.3	-285.63	18.02
Total Debt / Total Capital	61.18	95.66	126.72	153.87	15.27
LT Debt/Equity	61.03	228.71	-	-	5.92
Long-Term Debt / Total Capital	23.69	9.94	-	-	5.02
Total Liabilities / Total Assets	62.69	96.1	122.34	133.77	25.15
EBIT / Interest Expense	-2.04	-1.29	-1.04	0.44	0.55
EBITDA / Interest Expense	-1.89	-1.13	-0.73	0.6	0.86
(EBITDA - Capex) / Interest Expense	-1.89	-1.13	-0.73	0.6	0.86
Total Debt / EBITDA	-2.79	-3.44	-10.6	6.25	1.44
Net Debt / EBITDA	-2.17	-3.07	-10.29	5.68	-1.69
Total Debt / (EBITDA - Capex)	-2.79	-3.44	-10.6	6.25	1.44
Net Debt / (EBITDA - Capex)	-2.17	-3.07	-10.29	5.68	-1.69
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.04T	-12.11	13.34	51.31	26.26
Gross Profit, 1 Yr. Growth %	1.24T	-7.64	28.1	71.1	33.36
EBITDA, 1 Yr. Growth %	-	4.77	-65.59	-265.34	-26.81
EBITA, 1 Yr. Growth %	69.46	4.77	-65.59	-265.34	-26.81
EBIT, 1 Yr. Growth %	82.57	11.6	-57.16	-185.67	-36.21
Earnings From Cont. Operations, 1 Yr. Growth %	135.25	29.32	-52.98	-44.65	-276.45
Net Income, 1 Yr. Growth %	135.25	29.32	-52.98	-44.65	-276.45
Normalized Net Income, 1 Yr. Growth %	144.62	32.75	-52.88	-44.65	-19.63
Diluted EPS Before Extra, 1 Yr. Growth %	85.55	12.99	-55.07	-40	-166.66
Accounts Receivable, 1 Yr. Growth %	16.44	-32.27	49.54	174.7	-2.79
Inventory, 1 Yr. Growth %	-34.06	-21.14	-51.43	65.91	-14.34
Total Assets, 1 Yr. Growth %	641.45	-11.37	-14.1	7.02	20.64
Tangible Book Value, 1 Yr. Growth %	46.69	69.96	19.13	4.5	-116.94
Common Equity, 1 Yr. Growth %	-235.38	-90.79	-595.55	61.74	-367.14
Cash From Operations, 1 Yr. Growth %	114.26	-1.06	-54.52	-189.23	25.05
Levered Free Cash Flow, 1 Yr. Growth %	154.29	-95.57	-251.28	1.54T	-255.11
Unlevered Free Cash Flow, 1 Yr. Growth %	211.89	-82.36	-265.97	611.25	-139.08
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	215.96	-0.19	30.95	38.22
Gross Profit, 2 Yr. CAGR %	-	251.67	8.77	48.05	51.06
EBITDA, 2 Yr. CAGR %	-	-	-39.96	-24.58	10.01
EBITA, 2 Yr. CAGR %	73.93	33.24	-39.96	-24.58	10.01
EBIT, 2 Yr. CAGR %	80.54	42.74	-30.85	-39.42	-26.08
Earnings From Cont. Operations, 2 Yr. CAGR %	115.06	74.42	-22.02	-48.98	-1.18
Net Income, 2 Yr. CAGR %	115.06	74.42	-22.02	-48.98	-1.18
Normalized Net Income, 2 Yr. CAGR %	112.05	80.2	-20.91	-48.93	-33.3
Diluted EPS Before Extra, 2 Yr. CAGR %	78.42	44.8	-28.75	-47.94	-36.76
Accounts Receivable, 2 Yr. CAGR %	-	-11.19	0.64	102.68	63.41
Inventory, 2 Yr. CAGR %	-	-27.89	-38.11	-10.23	19.22
Total Assets, 2 Yr. CAGR %	815.67	156.35	-12.74	-4.12	13.63
Tangible Book Value, 2 Yr. CAGR %	47.79	57.9	42.29	11.57	-57.93
Common Equity, 2 Yr. CAGR %	38.42	-64.69	-32.44	183.11	107.86
Cash From Operations, 2 Yr. CAGR %	62.2	45.6	-32.92	-36.3	5.63
Levered Free Cash Flow, 2 Yr. CAGR %	21.45	-66.44	-74.11	351.09	390.14
Unlevered Free Cash Flow, 2 Yr. CAGR %	24.11	-25.82	-45.89	236.35	64.52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	124.5	14.66	29.37
Gross Profit, 3 Yr. CAGR %	-	-	151.16	26.5	42.98
EBITDA, 3 Yr. CAGR %	-	-	-	-15.85	-25.33
EBITA, 3 Yr. CAGR %	157.27	46.89	-15.15	-15.85	-25.33
EBIT, 3 Yr. CAGR %	163.74	53.79	-4.43	-25.73	-38.37
Earnings From Cont. Operations, 3 Yr. CAGR %	171.16	81.52	12.68	-30.44	-22.85
Net Income, 3 Yr. CAGR %	171.16	81.52	12.68	-30.44	-22.85
Normalized Net Income, 3 Yr. CAGR %	168.62	81.4	15.23	-29.78	-40.6
Diluted EPS Before Extra, 3 Yr. CAGR %	108.82	53.22	-1.97	-32.6	-43.47
Accounts Receivable, 3 Yr. CAGR %	-	-	5.66	40.65	58.65
Inventory, 3 Yr. CAGR %	-	-	-36.79	-14.02	-11.62
Total Assets, 3 Yr. CAGR %	980.65	320.43	78.06	-6.6	3.51
Tangible Book Value, 3 Yr. CAGR %	20.74	54.84	43.74	28.38	-40.48
Common Equity, 3 Yr. CAGR %	15.58	-43.91	-14.82	-9.62	177.68
Cash From Operations, 3 Yr. CAGR %	107.8	37.56	-1.21	-26.23	-20.24
Levered Free Cash Flow, 3 Yr. CAGR %	-	-59.72	-44.56	-3.41	209.82
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-35.23	-2.98	25.91	62.68
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	84.91
Gross Profit, 5 Yr. CAGR %	-	-	-	-	104.94
EBITA, 5 Yr. CAGR %	108.03	441.4	43.75	12.51	-5.86
EBIT, 5 Yr. CAGR %	111.15	456.52	54.39	5.95	-13.76
Earnings From Cont. Operations, 5 Yr. CAGR %	101.39	144.68	64.71	9.26	6.92
Net Income, 5 Yr. CAGR %	101.39	144.68	64.71	9.26	6.92
Normalized Net Income, 5 Yr. CAGR %	100.26	144.58	64.71	9.26	-7.41
Diluted EPS Before Extra, 5 Yr. CAGR %	77.57	103.6	35.82	-0.51	-17.65
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	25.79
Inventory, 5 Yr. CAGR %	-	-	-	-	-18.53
Total Assets, 5 Yr. CAGR %	-	-	294.94	132.76	48.77
Tangible Book Value, 5 Yr. CAGR %	14.2	26.39	28.94	35.82	-12.07
Common Equity, 5 Yr. CAGR %	11.24	-31.27	-6.76	7.18	21.7
Cash From Operations, 5 Yr. CAGR %	91.07	406.78	32.2	1.1	1.47
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	5.86	27.35
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	25.18	18.83